Macroaxis: Personalized Investing
Simple Personalized Investing

FRE FME FMEA FME3 Financials Hybrid Mix Moderate Action Alerts 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Collecting data for FMEA

Fresenius quote and profile

 
 Companies |  Insiders  | Dashboard  
     
26.15
  
STOCK
(1.35)  Macroaxis: -4.91 Down   4.91%  
Year To Date
47.2160.18
Last 1 Month(s)
25.4928.0
Trading Day 
26.1526.15
May 25 2013 

Diversification Suggestion

Use Fresenius to protect against small markets fluctuations. The stock experiences very speculative upward sentiment.
Analyze Fresenius Medical Care Trend or Check current 30 days Fresenius correlation with market (S&P 500)
1 Month Beta 0.6  
Highest Price:  
Lowest Price:  
28.0  
25.49  
April 25 2013 
April 30 2013 
As returns on market increase, Fresenius returns are expected to increase less than the market. However during bear market, the loss on holding Fresenius will be expected to be smaller as well.
Fresenius Medical Care AG   Co KGAA Small BetaFresenius Medical Care Beta Legend
FMEA Germany XETRA #US3580291066DE
Fresenius Medical Care AG Co KGAA
Healthcare
Hospitals
Benchmark S&P 500
http://www.fmc-ag.com
Contact Number: 49 6172 6090
Currency: EUR - Euro
Traded on XETRA Stock Exchange
    
Current Valuation24.77 B
Shares Outstanding613.43 M
Revenue14.08 B
Gross Profit3.83 B
 United States SP 500   0.06 % Macroaxis: 0.06 Moved Down  
 
 Germany DAX   0.56 % Macroaxis: 0.56 Moved Down  
 
 thisRed FMEA FMEA.DE agains markets  4.91 % Macroaxis: change 4.91 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Fresenius Leadership

Emanuele Gatti CEO of Europe, Middle East, Africa and Latin America for Fresenius Medical Care Management Ag, Chief Strategist of Fresenius Medical Care Management Ag and Member of Management Board for of Fresenius Medical Care Management Ag
Roberto Fust CEO of Asia Pacific Division - Fresenius Medical Care Management AG and Member of Management Board - Fresenius Medical Care Management AG
Robert Powell Chairman of Management Board - Fresenius Medical Care Management AG and CEO of Fresenius Medical Care Management AG
Gerd Krick Chairman of Supervisory Board, Chairman of Nomination Committee, Member of Audit and Corporate Governance Committee, Member of Joint Committee and member of the Supervisory Board of Management AG

Fresenius Price and Market Media

The median price of Fresenius for the period between Thu, Apr 25, 2013 and Sat, May 25, 2013 is 26.15 with a coefficient of variation of 3.11. The daily time series for the period is distributed with a sample standard deviation of 0.82, arithmetic mean of 26.49, and mean deviation of 0.69. The Stock did not receive any noticable media coverage during the period.
Fresenius         SP 500
Price Growth (%)
 

Fresenius Summary

Fresenius Medical Care AG Co KGAA [FMEA] is traded on XETRA Stock Exchange in Germany. It is located in Bad Homburg, and employs 86,153 people. The company currently falls under 'Large-Cap' category with current market capitalization of 15.98 B. Fresenius Medical Care AG Co KGAA operates under Healthcare sector and is part of Hospitals industry. This company has 613.43 M outstanding shares.
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, operates in the field of dialysis care and dialysis solutions for the treatment of endstage renal disease. more
Past Market
Over 30
Days
0
Out Of
100
 
Chance of
Less
Than
47 %
 
Follow Fresenius with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Fresenius to your reader
 

Fresenius Research Report

Fresenius vs. FRE

Correlation analysis and fundamentals comparison between Fresenius Medical Care and Fresenius SE KGaA

Fresenius Executives

Michael Brosnan CFO of Fresenius Medical Care Management AG and Member of Management Board - Fresenius Medical Care Management AG

Fresenius Directors

Rainer Runte Chief Admin. Officer of Global Law, Compliance and Intellectual Property - Fresenius Medical Care Management AG, Corporate Bus. Devel. and Labour Relation Director of Fresenius Medical Care Management AG and Member of the Management Board - Fresenius Medical Care Management AG

Fresenius Fundamentals

Cash per Share vs One Year Low
EBITDA vs Current Ratio
Cash per Share vs Z Score
Price to Earning vs Current Ratio

Fresenius vs Competition

Fresenius vs. Fresenius SE Co KGaA
Fresenius vs. Fresenius Medical Care AG Co KGAA
Fresenius vs. Fresenius Medical Care AG Co KGAA
Fresenius vs. Rhoen Klinikum AG
Fresenius vs. Curanum AG
Fresenius vs. MarseilleKliniken AG
Fresenius vs. MaternusKliniken AG

Fresenius May 25 2013 Opportunity Range

Information Ratio(0.18)
Maximum Drawdown10.48
Value At Risk(4.91)
Potential Upside2.2

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium